Brief: ROVI H1 Revenue EUR 329.3 Million

Laboratorios Farmaceuticos Rovi

31/07/2024 06:37

Jul 31 (Reuters) - ROVI H1 free cash flow EUR 11.2 million.
* H1 EBIT EUR 56.5 million
* H1 EBITDA EUR 69.9 million
* H1 net income EUR 44.3 million